• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜癌的分子病理学。

Molecular pathology of endometrial carcinoma.

机构信息

Department of Pathology and Molecular Genetics and Research Laboratory, Hospital Universitari Arnau de Vilanova, University of Lleida, IRBLLEIDA, Lleida, Spain.

出版信息

Histopathology. 2013 Jan;62(1):111-23. doi: 10.1111/his.12053.

DOI:10.1111/his.12053
PMID:23240673
Abstract

This review paper discusses the main molecular alterations of endometrial carcinoma, the most common cancer of the female genital tract. Two clinicopathological variants are recognized: the oestrogen-related (type I, endometrioid carcinoma) and the non-oestrogen-related (type II, non-endometrioid carcinoma). Whereas type I shows microsatellite instability and mutations in PTEN, PIK3CA, K-RAS and CTNNB1 (beta-catenin), type II exhibits TP53 mutations and chromosomal instability. Recent investigations regarding the role of non-coding RNA have provided important information regarding tumour progression. Understanding pathogenesis at the molecular level is essential for identifying biomarkers of potential use in targeted therapies.

摘要

这篇综述文章讨论了子宫内膜癌的主要分子改变,子宫内膜癌是女性生殖道最常见的癌症。两种临床病理变异型被识别:雌激素相关型(I 型,子宫内膜样癌)和非雌激素相关型(II 型,非子宫内膜样癌)。I 型表现为微卫星不稳定和 PTEN、PIK3CA、K-RAS 和 CTNNB1(β-连环蛋白)的突变,而 II 型则表现为 TP53 突变和染色体不稳定性。最近关于非编码 RNA 作用的研究为肿瘤进展提供了重要信息。在分子水平上理解发病机制对于鉴定可能用于靶向治疗的生物标志物至关重要。

相似文献

1
Molecular pathology of endometrial carcinoma.子宫内膜癌的分子病理学。
Histopathology. 2013 Jan;62(1):111-23. doi: 10.1111/his.12053.
2
High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.子宫内膜癌患者术前刮宫和子宫切除标本中分子肿瘤改变的高度一致性。
Gynecol Oncol. 2014 May;133(2):197-204. doi: 10.1016/j.ygyno.2014.02.012. Epub 2014 Feb 18.
3
Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.卵巢和子宫内膜样腺癌在微卫星不稳定性、PTEN表达及ARID1A表达方面具有不同特征。
Histopathology. 2015 Mar;66(4):517-28. doi: 10.1111/his.12543. Epub 2014 Dec 22.
4
Molecular approaches for classifying endometrial carcinoma.用于子宫内膜癌分类的分子方法。
Gynecol Oncol. 2017 Apr;145(1):200-207. doi: 10.1016/j.ygyno.2016.12.015. Epub 2016 Dec 29.
5
High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.对原发性子宫内膜癌中的 PIK3CA、PTEN、KRAS、FBXW7 和 TP53 突变进行高通量检测。
Gynecol Oncol. 2013 Feb;128(2):327-34. doi: 10.1016/j.ygyno.2012.11.037. Epub 2012 Dec 4.
6
PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.PIK3CA 突变和扩增在子宫内膜样子宫内膜癌中的作用:与其他遗传缺陷和肿瘤的临床病理状态的关系。
Hum Pathol. 2011 Nov;42(11):1710-9. doi: 10.1016/j.humpath.2010.01.030. Epub 2011 Apr 29.
7
Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.哺乳动物雷帕霉素靶蛋白与侵袭性 II 型子宫内膜癌及不良预后的相关性:一种潜在的治疗靶点。
Hum Pathol. 2013 Feb;44(2):218-25. doi: 10.1016/j.humpath.2012.05.008. Epub 2012 Sep 3.
8
Novel molecular profiles of endometrial cancer-new light through old windows.子宫内膜癌的新型分子图谱——透过旧窗口的新曙光
J Steroid Biochem Mol Biol. 2008 Feb;108(3-5):221-9. doi: 10.1016/j.jsbmb.2007.09.020. Epub 2007 Sep 15.
9
Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers.复发性 I 期、1 级子宫内膜样腺癌的分子标志物。
Gynecol Oncol. 2019 Jun;153(3):517-520. doi: 10.1016/j.ygyno.2019.03.100. Epub 2019 Mar 22.
10
Endometrial carcinoma: pathology and genetics.子宫内膜癌:病理学与遗传学
Pathology. 2007 Feb;39(1):72-87. doi: 10.1080/00313020601136153.

引用本文的文献

1
Iron Deficiency and Iron Deficiency Anemia: A Comprehensive Overview of Established and Emerging Concepts.缺铁与缺铁性贫血:既定概念与新兴概念的全面概述
Pharmaceuticals (Basel). 2025 Jul 25;18(8):1104. doi: 10.3390/ph18081104.
2
Mechanisms and benefits of phytochemicals as an alternative therapeutic strategy in female cancers.植物化学物质作为女性癌症替代治疗策略的作用机制及益处
Chin Herb Med. 2025 Apr 11;17(3):448-463. doi: 10.1016/j.chmed.2025.04.002. eCollection 2025 Jul.
3
Mismatch Repair Protein Deficiency and Its Relationship with Clinicopathological Factors in Endometrial Cancer: A Retrospective Study.
错配修复蛋白缺陷及其与子宫内膜癌临床病理因素的关系:一项回顾性研究
J Cancer. 2025 Jun 12;16(9):2778-2786. doi: 10.7150/jca.112935. eCollection 2025.
4
EPM2 AIP1 immunohistochemistry as a surrogate of promoter methylation analysis in endometrial carcinoma.EPM2 AIP1免疫组化作为子宫内膜癌启动子甲基化分析的替代方法
Virchows Arch. 2025 Jun 5. doi: 10.1007/s00428-025-04132-3.
5
CD8+ T cell activation in endometrial cancer: prognostic implications and potential for personalized therapy.子宫内膜癌中CD8 + T细胞活化:预后意义及个性化治疗潜力
Front Immunol. 2025 Apr 28;16:1542669. doi: 10.3389/fimmu.2025.1542669. eCollection 2025.
6
Advances and challenges in the use of liquid biopsy in gynaecological oncology.液体活检在妇科肿瘤学中的应用进展与挑战
Heliyon. 2024 Oct 15;10(20):e39148. doi: 10.1016/j.heliyon.2024.e39148. eCollection 2024 Oct 30.
7
Integrated analysis and experiments uncover the function of disulfidptosis in predicting immunotherapy effectiveness and delineating immune landscapes in uterine corpus endometrial carcinoma.综合分析和实验揭示了二硫键死亡在预测免疫治疗效果和描绘子宫体子宫内膜癌免疫景观中的作用。
Front Immunol. 2024 Oct 9;15:1454730. doi: 10.3389/fimmu.2024.1454730. eCollection 2024.
8
Quantitative Assessment of Polarization and Elastic Properties of Endometrial Tissue for Precancer/Cancer Diagnostics Using Multimodal Optical Coherence Tomography.使用多模态光学相干断层扫描对子宫内膜组织的极化和弹性特性进行定量评估以用于癌前/癌症诊断
Diagnostics (Basel). 2024 Sep 25;14(19):2131. doi: 10.3390/diagnostics14192131.
9
The role of extracellular vesicles in the pathogenesis of gynecological cancer.细胞外囊泡在妇科癌症发病机制中的作用。
Front Oncol. 2024 Sep 26;14:1477610. doi: 10.3389/fonc.2024.1477610. eCollection 2024.
10
Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma.建立与细胞坏死相关的子宫体子宫内膜癌预后模型。
Sci Rep. 2024 Feb 21;14(1):4257. doi: 10.1038/s41598-024-54651-3.